MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Naviscan Inc.

Indian market opens to InspireMD mesh coronary stent | Deals roundup

By Leave a Comment

InspireMD Inc. (OTC:NSPR) launched its MGuard coronary stent system in India.

The Tel Aviv-based firm’s flagship product is the first mesh-based coronary stent system available in the country, the company said.

The CE Mark approved MGuard stent is wrapped with a polymer mesh sleeve designed to protect acute MI patients against embolism. Kirloskar Technologies P. Ltd., which has already closed an initial order for the stent in India, will be InspireMD’s distributor of the product, according to the company.

Medtronic touts heart failure treatment study | Research roundup

By Leave a Comment

Clinical trials roundup

Medtronic Inc. (NYSE:MDT) said results from the Improve HF study demonstrate that select guideline-based outpatient heart failure measures can increase patient survival and might be useful for improving patient quality of care.

The Improve HF (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting) study is the largest U.S.-based outpatient heart failure clinical study. The results of the study were published in the journal Circulation.

Neoprobe and Naviscan ink licensing deal for imaging technology

By Leave a Comment

Neoprobe logo

Neoprobe Corp. (NYSE Amex:NEOP) reached an agreement to license an imaging technology patent from San Diego-based Naviscan Inc.

Dublin, Ohio-based Neoprobe will use Naviscan’s technology in conjunction with its own gamma-detection systems, which are used to evaluate the potential spread of cancer to lymph node tissues and organs, according to a prepared statement Naviscan.